ProPublicaIn 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies.
Now, under RFK Jr., the agency is poised to reverse itself — despite the fact that few clinical studies support claims of the peptides’ effectiveness or safety.
https://www.propublica.org/article/peptide-safety-fda-compounding-pharmacies?utm_source=mastodon&utm_medium=social&utm_campaign=mastodon-post
RFK Jr. May Reverse a Peptide Ban He Calls “Illegal.” Former FDA Officials Say He Mischaracterized Their Work.
The agency’s 2023 decision to place 19 peptides on the “unsafe” list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, there’s been little new science.
r06ue1